Table 2 Proportions of CLA⁺ Tregs among CD4⁺ T cells in patients with BS with different clinical features

Female

1.13 (0.50, 1.74)

1.22 (0.83, 1.91)

-0.711

0.477

7.78 (2.80, 15.23)

8.36 (4.97, 14.30)

-0.417

0.677

Oral ulcer

1.18 (0.68, 1.91)

0.73 (0.30, 1.76)

-0.978

0.328

7.91 (3.92, 14.92)

2.23 (1.90, 12.34)

-1.119

0.263

Genital ulcer

1.27 (0.84, 1.96)

1.00 (0.45, 1.88)

-1.763

0.078

10.45 (5.09, 15.85)

6.33 (2.55

-2.380

0.017

Pseudofolliculitis

1.12 (0.71, 1.97)

1.22 (0.56, 1.75)

-0.522

0.601

8.55 (5.15, 15.25)

7.36 (2.55, 13.30)

-1.142

0.254

Erythema nodosum

1.06 (0.45, 1.68)

1.29 (0.71, 1.97)

-1.174

0.240

8.47 (2.52, 14.42)

7.81 (4.75, 14.83)

-0.241

0.809

Uveitis

1.32 (0.65, 2.32)

1.12 (0.60, 1.78)

-0.552

0.581

7.36 (2.78, 16.97)

7.91 (3.81, 12.93)

-0.471

0.638

Arthritis

1.49 (0.56, 2.33)

1.09 (0.64, 1.73)

-1.177

0.239

10.99 (2.44, 17.07)

7.78 (4.27, 12.93)

-0.501

0.616

Gastrointestinal involvement

1.29 (0.73, 1.93)

1.12 (0.61, 1.82)

-0.440

0.660

5.88 (2.49, 14.43)

8.00 (3.69, 14.92)

-0.412

0.680

Neurological lesion

1.58 (1.08, 2.57)

1.09 (0.56, 1.75)

-2.405

0.016

9.64 (6.55, 15.85)

7.36 (2.80, 13.30)

-1.560

0.119

Fever

0.83 (0.34, 2.12)

1.20 (0.69, 1.86)

-1.216

0.224

5.27 (1.75, 11.93)

8.13 (4.26, 14.67)

-1.370

0.171

Arterial aneurysm

0.70 (0.47, 0.98)

1.27 (0.74, 1.97)

-2.777

0.005

5.09 (2.28, 7.91)

8.25 (3.96, 15.25)

-2.017

0.044

Venous thrombus

1.03 (0.76, 1.69)

1.25 (0.60, 1.93)

-0.400

0.689

9.64 (5.39, 14.92)

7.78 (2.82, 14.43)

-0.588

0.557

Positive HLA-B51

1.26 (0.73, 2.59)

1.18 (0.67, 1.91)

-0.608

0.543

13.45 (5.40, 21.91)

7.53 (4.17, 14.30)

-1.816

0.069

ESR > 20 mm/h

0.83 (0.39, 1.31)

1.27 (0.78, 1.97)

-2.490

0.013

5.27 (2.18, 9.23)

8.51 (4.66, 15.70)

-2.164

0.031

CRP > 10 mg/L

0.89 (0.40, 1.84)

1.28 (0.68, 1.87)

-1.671

0.095

5.75 (2.30, 10.36)

8.05 (3.95, 16.03)

-1.630

0.103